| 17alpha-ethynylestradiol | multiple interactions | EXP | | 6480464 | [Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of CYP2D26 mRNA | CTD | PMID:17942748 |
| 2,3,7,8-tetrachlorodibenzodioxine | decreases expression | ISO | RGD:2471 | 6480464 | Tetrachlorodibenzodioxin results in decreased expression of CYP2D2 mRNA | CTD | PMID:18796159 |
| 2,3,7,8-tetrachlorodibenzodioxine | decreases expression | ISO | RGD:2471 | 6480464 | Tetrachlorodibenzodioxin results in decreased expression of CYP2D2 mRNA | CTD | PMID:18796159 PMID:21215274 |
| 2,3,7,8-tetrachlorodibenzodioxine | multiple interactions | EXP | | 6480464 | [Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of CYP2D26 mRNA | CTD | PMID:17942748 |
| 2,4-dinitrotoluene | affects expression | ISO | RGD:2471 | 6480464 | 2,4-dinitrotoluene affects the expression of CYP2D26 mRNA | CTD | PMID:21346803 |
| 2,6-dinitrotoluene | affects expression | ISO | RGD:2471 | 6480464 | 2,6-dinitrotoluene affects the expression of CYP2D26 mRNA | CTD | PMID:21346803 |
| 2-nitroanisole | increases oxidation | ISO | RGD:2471 | 6480464 | CYP2D2 protein results in increased oxidation of 2-nitroanisole | CTD | PMID:21218109 |
| 3,3',4,4'-tetrachlorobiphenyl | multiple interactions | EXP | | 6480464 | 3,4,3',4'-tetrachlorobiphenyl inhibits the reaction [Dietary Fats results in increased expression of CYP2D26 mRNA] | CTD | PMID:19467301 |
| 4,4'-diaminodiphenylmethane | affects expression | EXP | | 6480464 | 4,4'-diaminodiphenylmethane affects the expression of CYP2D26 mRNA | CTD | PMID:18648102 |
| 5-methoxy-N,N-diisopropyltryptamine | increases metabolic processing | ISO | RGD:2471 | 6480464 | CYP2D2 protein results in increased metabolism of 5-methoxy-N,N-diisopropyltryptamine | CTD | PMID:18191824 |
| acetonitrile | multiple interactions | ISO | RGD:2471 | 6480464 | acetonitrile inhibits the reaction [CYP2D2 protein results in increased metabolism of 3-(2-(N,N-diethyl-N-methylammonium)ethyl)-7-methoxy-4-methylcoumarin] | CTD | PMID:19858067 |
| ammonium chloride | affects expression | ISO | RGD:2471 | 6480464 | Ammonium Chloride affects the expression of CYP2D2 mRNA | CTD | PMID:16483693 |
| cis-ketoconazole | multiple interactions | ISO | RGD:2471 | 6480464 | Ketoconazole inhibits the reaction [CYP2D2 protein results in increased metabolism of 3-(2-(N,N-diethyl-N-methylammonium)ethyl)-7-methoxy-4-methylcoumarin] | CTD | PMID:19858067 |
| cis-ketoconazole | decreases activity | ISO | RGD:2471 | 6480464 | Ketoconazole results in decreased activity of CYP2D26 protein | CTD | PMID:15879494 |
| clotrimazole | multiple interactions | ISO | RGD:2471 | 6480464 | Clotrimazole inhibits the reaction [CYP2D2 protein results in increased metabolism of 3-(2-(N,N-diethyl-N-methylammonium)ethyl)-7-methoxy-4-methylcoumarin] | CTD | PMID:19858067 |
| copper(II) chloride | increases expression | EXP | | 6480464 | cupric chloride results in increased expression of CYP2D26 mRNA | CTD | PMID:17211630 |
| dextromethorphan | affects metabolic processing | ISO | RGD:2471 | 6480464 | CYP2D26 protein affects the metabolism of Dextromethorphan | CTD | PMID:15879494 |
| dextromethorphan | decreases methylation | ISO | RGD:2471 | 6480464 | CYP2D2 protein results in decreased methylation of Dextromethorphan | CTD | PMID:11911841 |
| dimethyl sulfoxide | multiple interactions | ISO | RGD:2471 | 6480464 | Dimethyl Sulfoxide inhibits the reaction [CYP2D2 protein results in increased metabolism of 3-(2-(N,N-diethyl-N-methylammonium)ethyl)-7-methoxy-4-methylcoumarin] | CTD | PMID:19858067 |
| doxorubicin | increases expression | EXP | | 6480464 | Doxorubicin results in increased expression of CYP2D26 mRNA | CTD | PMID:15033991 |
| fluconazole | decreases expression | EXP | | 6480464 | Fluconazole results in decreased expression of CYP2D26 mRNA | CTD | PMID:16730040 |
| fluoxetine | multiple interactions | ISO | RGD:2471 | 6480464 | Fluoxetine inhibits the reaction [CYP2D2 protein results in increased metabolism of 3-(2-(N,N-diethyl-N-methylammonium)ethyl)-7-methoxy-4-methylcoumarin] | CTD | PMID:19858067 |
| formaldehyde | decreases expression | ISO | RGD:2471 | 6480464 | Formaldehyde results in decreased expression of CYP2D2 mRNA | CTD | PMID:17285311 |
| furan | increases methylation | ISO | RGD:2471 | 6480464 | furan results in increased methylation of CYP2D2 gene | CTD | PMID:22079235 |
| lamotrigine | increases glutathionylation | ISO | RGD:2471 | 6480464 | CYP2D2 protein results in increased glutathionylation of lamotrigine | CTD | PMID:19961160 |
| mitomycin C | decreases activity | ISO | RGD:2471 | 6480464 | Mitomycin results in decreased activity of CYP2D26 protein | CTD | PMID:15696929 |
| N-nitrosodiethylamine | decreases expression | ISO | RGD:2471 | 6480464 | Diethylnitrosamine results in decreased expression of CYP2D2 mRNA | CTD | PMID:20360939 |
| N-nitrosodiethylamine | decreases expression | ISO | RGD:2471 | 6480464 | Diethylnitrosamine results in decreased expression of CYP2D26 mRNA | CTD | PMID:19638242 |
| ochratoxin A | decreases expression | ISO | RGD:2471 | 6480464 | ochratoxin A results in decreased expression of CYP2D26 mRNA | CTD | PMID:18417182 |
| paracetamol | affects expression | ISO | RGD:2471 | 6480464 | Acetaminophen affects the expression of CYP2D26 mRNA | CTD | PMID:17366322 |
| perfluorooctane-1-sulfonic acid | affects expression | EXP | | 6480464 | perfluorooctane sulfonic acid affects the expression of CYP2D26 mRNA | CTD | PMID:19429403 |
| perfluorooctanoic acid | affects expression | EXP | | 6480464 | perfluorooctanoic acid affects the expression of CYP2D26 mRNA | CTD | PMID:19429403 |
| phenacetin | affects metabolic processing | ISO | RGD:2471 | 6480464 | CYP2D26 protein affects the metabolism of Phenacetin | CTD | PMID:15879494 |
| phenobarbital | increases expression | ISO | RGD:2471 | 6480464 | Phenobarbital results in increased expression of CYP2D26 mRNA | CTD | PMID:15596064 |
| propiconazole | decreases expression | EXP | | 6480464 | propiconazole results in decreased expression of CYP2D26 mRNA | CTD | PMID:16730040 |
| propranolol | multiple interactions | ISO | RGD:2471 | 6480464 | Propranolol inhibits the reaction [CYP2D2 protein results in increased metabolism of 3-(2-(N,N-diethyl-N-methylammonium)ethyl)-7-methoxy-4-methylcoumarin] | CTD | PMID:19858067 |
| quinidine | multiple interactions | ISO | RGD:2471 | 6480464 | Quinidine inhibits the reaction [CYP2D2 protein results in increased metabolism of 3-(2-(N,N-diethyl-N-methylammonium)ethyl)-7-methoxy-4-methylcoumarin] | CTD | PMID:19858067 |
| quinine | decreases activity | ISO | RGD:2471 | 6480464 | Quinine results in decreased activity of CYP2D26 protein | CTD | PMID:15879494 |
| quinine | multiple interactions | ISO | RGD:2471 | 6480464 | Quinine inhibits the reaction [CYP2D2 protein results in increased metabolism of 3-(2-(N,N-diethyl-N-methylammonium)ethyl)-7-methoxy-4-methylcoumarin] | CTD | PMID:19858067 |
| quinine | decreases activity | ISO | RGD:2471 | 6480464 | Quinine results in decreased activity of CYP2D2 protein | CTD | PMID:12814958 |
| sodium dichromate | affects expression | ISO | RGD:2471 | 6480464 | sodium bichromate affects the expression of CYP2D2 mRNA | CTD | PMID:22110744 |
| tetrachloromethane | increases expression | ISO | RGD:2471 | 6480464 | Carbon Tetrachloride results in increased expression of CYP2D26 protein | CTD | PMID:17606319 |
| vancomycin | increases expression | EXP | | 6480464 | Vancomycin results in increased expression of CYP2D26 mRNA | CTD | PMID:18930951 |